Hepatopulmonary – Syndrome, Causes and Treatment
Hepatopulmonary syndrome is a serious complication of liver disease in which abnormal widening of lung blood vessels leads to low oxygen levels in the blood.
Things worth knowing about "Hepatopulmonary"
Hepatopulmonary syndrome is a serious complication of liver disease in which abnormal widening of lung blood vessels leads to low oxygen levels in the blood.
What Does Hepatopulmonary Mean?
The term hepatopulmonary combines the Latin words hepar (liver) and pulmo (lung). It describes the interaction or joint involvement of the liver and lungs in a disease process. In clinical practice, the term is most commonly used in connection with hepatopulmonary syndrome (HPS) – a serious complication of advanced liver disease.
Definition of Hepatopulmonary Syndrome
Hepatopulmonary syndrome is a condition in which chronic liver disease or portal hypertension (elevated pressure in the portal vein) leads to abnormal widening of small blood vessels within the lungs. These so-called intrapulmonary vascular dilatations (IPVD) impair gas exchange and cause a drop in blood oxygen levels, resulting in hypoxemia.
Causes
Hepatopulmonary syndrome typically develops as a consequence of:
- Liver cirrhosis – the most common underlying condition
- Chronic hepatitis (e.g., hepatitis B or C)
- Non-cirrhotic portal hypertension
- Acute liver failure (less common)
- Congenital liver diseases (e.g., biliary atresia in children)
Impaired liver function leads to increased release of vasoactive substances – most notably nitric oxide (NO) – which cause excessive dilation of the pulmonary capillaries and disrupt normal oxygen uptake.
Symptoms
The symptoms of hepatopulmonary syndrome often develop gradually and may initially be non-specific:
- Dyspnea (shortness of breath), especially during physical exertion
- Platypnea – worsening breathlessness when standing upright, relief when lying down (a hallmark feature)
- Orthodeoxia – a drop in oxygen saturation when moving from lying to standing
- Cyanosis (bluish discoloration of lips and fingernails)
- Clubbing of fingers and toes
- General signs of liver disease: jaundice, ascites, spider angiomas
Diagnosis
Diagnosis of hepatopulmonary syndrome is based on a combination of findings:
- Arterial blood gas analysis: Confirms hypoxemia (reduced partial pressure of oxygen, PaO2 < 80 mmHg)
- Contrast echocardiography: Detects intrapulmonary shunts using agitated saline bubble study
- Tc-99m MAA lung perfusion scan: Quantifies the extent of intrapulmonary shunting
- Pulmonary function tests and high-resolution CT of the chest
- Laboratory tests to assess liver function (Child-Pugh score, MELD score)
Treatment
To date, there is no approved medication that cures hepatopulmonary syndrome. The only potentially curative treatment is:
- Liver transplantation: This is considered the treatment of choice and leads to complete or significant resolution of pulmonary changes in most patients. Patients with severe HPS receive priority points (MELD exception points) for organ allocation.
Supportive measures include:
- Long-term supplemental oxygen therapy to relieve hypoxemia
- Treatment of the underlying liver disease (e.g., antiviral therapy for hepatitis)
- In selected cases: Transjugular intrahepatic portosystemic shunt (TIPS) or experimental therapies – evidence remains limited
Prognosis
Without treatment, the prognosis of hepatopulmonary syndrome is poor. The severity of hypoxemia correlates with mortality. Following successful liver transplantation, most patients recover well, although normalization of lung function may take several months.
References
- European Association for the Study of the Liver (EASL): Clinical Practice Guidelines on the management of hepatic encephalopathy and hepatopulmonary syndrome. Journal of Hepatology, 2022.
- Rodríguez-Roisin R, Krowka MJ: Hepatopulmonary Syndrome – A Liver-Induced Lung Vascular Disorder. New England Journal of Medicine, 2008; 358(22): 2378-2387.
- Krowka MJ et al.: Hepatopulmonary Syndrome and Portopulmonary Hypertension: A Report of the Multicenter Liver Transplant Database. Liver Transplantation, 2004; 10(2): 174-182.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Hepatopulmonary-en